Task: Answer the following question about the molecule with SMILES Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+].
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Clinical Phase unknown
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+]
Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+]
sodium;2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]purin-6-olate
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Clinical Phase unknown